Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial
published in: BMC Cancer
date of publication: 2014-07-15
language: English
main subject: phase III clinical trial, chemotherapy, trastuzumab
Cites articles 37
Date
Title
Article - wd:Q34468964